INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.77
-0.30 (-3.72%)
At close: Apr 3, 2025, 4:00 PM
7.74
-0.03 (-0.44%)
Pre-market: Apr 4, 2025, 4:05 AM EDT

INmune Bio Statistics

Total Valuation

INmune Bio has a market cap or net worth of $178.17 million. The enterprise value is $157.63 million.

Market Cap 178.17M
Enterprise Value 157.63M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

INmune Bio has 22.93 million shares outstanding. The number of shares has increased by 10.92% in one year.

Current Share Class 22.93M
Shares Outstanding 22.93M
Shares Change (YoY) +10.92%
Shares Change (QoQ) +10.21%
Owned by Insiders (%) 19.72%
Owned by Institutions (%) 27.24%
Float 14.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12,726.32
Forward PS n/a
PB Ratio 5.39
P/TBV Ratio 11.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 11,259.32
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.01.

Current Ratio 3.14
Quick Ratio 3.09
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -54.04

Financial Efficiency

Return on equity (ROE) is -119.83% and return on invested capital (ROIC) is -65.75%.

Return on Equity (ROE) -119.83%
Return on Assets (ROA) -55.19%
Return on Invested Capital (ROIC) -65.75%
Return on Capital Employed (ROCE) -131.83%
Revenue Per Employee $824
Profits Per Employee -$2.48M
Employee Count 17
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.04% in the last 52 weeks. The beta is 1.88, so INmune Bio's price volatility has been higher than the market average.

Beta (5Y) 1.88
52-Week Price Change -29.04%
50-Day Moving Average 8.44
200-Day Moving Average 6.80
Relative Strength Index (RSI) 47.77
Average Volume (20 Days) 262,905

Short Selling Information

The latest short interest is 5.58 million, so 24.31% of the outstanding shares have been sold short.

Short Interest 5.58M
Short Previous Month 5.42M
Short % of Shares Out 24.31%
Short % of Float 37.34%
Short Ratio (days to cover) 22.60

Income Statement

In the last 12 months, INmune Bio had revenue of $14,000 and -$42.08 million in losses. Loss per share was -$2.11.

Revenue 14,000
Gross Profit 14,000
Operating Income -42.64M
Pretax Income -37.74M
Net Income -42.08M
EBITDA n/a
EBIT -42.64M
Loss Per Share -$2.11
Full Income Statement

Balance Sheet

The company has $20.92 million in cash and $384,000 in debt, giving a net cash position of $20.54 million or $0.90 per share.

Cash & Cash Equivalents 20.92M
Total Debt 384,000
Net Cash 20.54M
Net Cash Per Share $0.90
Equity (Book Value) 32.10M
Book Value Per Share 1.44
Working Capital 15.44M
Full Balance Sheet

Cash Flow

Operating Cash Flow -33.36M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -304,535.71%
Pretax Margin -300,585.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

INmune Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.92%
Shareholder Yield -10.92%
Earnings Yield -23.62%
FCF Yield n/a

Analyst Forecast

The average price target for INmune Bio is $24.33, which is 213.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $24.33
Price Target Difference 213.13%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 534.13%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

INmune Bio has an Altman Z-Score of 4.46 and a Piotroski F-Score of 2.

Altman Z-Score 4.46
Piotroski F-Score 2